The acute respiratory syndrome coronavirus 2 infection ( SARS-Cov2), termed COVID-19 is an extremely heterogene-ous disease and challenging in its clinical management. We performed a narrative review on the current treatment status of this pathology Objectives: To identify the proposed treatments for COVID-19 and the evidence of impact of these drugs on survival, length of stay and invasive ventilation: Methodology: We reviewed databases using search terms COVID-19,Coronavirus and treatment. Conclusion: There is evidence of clear benefit in the use of corticoste-roids, especially dexamethasone and tocilizumab for the inflammatory phase treatment of COVID-19. The evidence for use of convalescent plasma, antimalarials and other strategies is still small and nuclear.